Cameron Fraser

Cameron Fraser

Harvard University

H-index: 6

North America-United States

About Cameron Fraser

Cameron Fraser, With an exceptional h-index of 6 and a recent h-index of 6 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Apoptosis, mitochondria, cancer therapeutics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Activation of lysosomal iron triggers ferroptosis in cancer

AI is a viable alternative to high throughput screening: a 318-target study

Precision diet and lipid modulating agents to induce lipid oxidation in breast cancer

Functional genomic screens with death rate analyses reveal mechanisms of drug action

Abstract B109: Uncovering novel vulnerabilities in ovarian cancer by studying cell death in neoplastic transformation

Apoptosis inducing agent 1 enhances cancer therapy-induced apoptosis by direct interaction with BAX and BAK

p53 controls choice between apoptotic and non-apoptotic death following DNA damage

Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX

Cameron Fraser Information

University

Position

___

Citations(all)

840

Citations(since 2020)

660

Cited By

447

hIndex(all)

6

hIndex(since 2020)

6

i10Index(all)

6

i10Index(since 2020)

6

Email

University Profile Page

Google Scholar

Cameron Fraser Skills & Research Interests

Apoptosis

mitochondria

cancer therapeutics

Top articles of Cameron Fraser

Activation of lysosomal iron triggers ferroptosis in cancer

2024/4/8

Sebastian Müller
Sebastian Müller

H-Index: 3

Cameron Fraser
Cameron Fraser

H-Index: 5

AI is a viable alternative to high throughput screening: a 318-target study

Scientific Reports

2024/4/2

Precision diet and lipid modulating agents to induce lipid oxidation in breast cancer

Cancer Research

2024/3/22

Cameron Fraser
Cameron Fraser

H-Index: 5

Functional genomic screens with death rate analyses reveal mechanisms of drug action

Nature Chemical Biology

2024/3/13

Abstract B109: Uncovering novel vulnerabilities in ovarian cancer by studying cell death in neoplastic transformation

Cancer Research

2024/3/4

Apoptosis inducing agent 1 enhances cancer therapy-induced apoptosis by direct interaction with BAX and BAK

Cancer Research

2023/4/4

p53 controls choice between apoptotic and non-apoptotic death following DNA damage

bioRxiv

2023/5/17

Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX

Cancer Research

2023/10/13

Targeting endogenous and therapy-induced dependence on BCL-XL in high grade serous ovarian carcinoma

Cancer Research

2023/4/4

Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complex

iScience

2022/11/18

Heightened apoptotic priming of vascular cells across tissues and life span predisposes them to cancer therapy–induced toxicities

Science Advances

2022/11/9

A Mesenchymal Tumor Cell State Confers Increased Dependency on the BCL-XL Antiapoptotic Protein in Kidney Cancer

Cancer Research

2022/7/15

Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics

Nature communications

2022/10/2

LKB1 loss rewires JNK-induced apoptotic protein dynamics through NUAKs and sensitizes KRAS-mutant NSCLC to combined KRASG12C + MCL-1 blockade

Cancer Research

2022/6/15

LKB1 loss rewires stress signaling-induced apoptotic protein dynamics and sensitizes KRAS-mutant non-small cell lung cancers to combined MAPK + MCL-1 …

Cancer Research

2021/7/1

See List of Professors in Cameron Fraser University(Harvard University)